A detailed history of D. E. Shaw & Co., Inc. transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 69,108 shares of MGTX stock, worth $286,798. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,108
Previous 68,790 0.46%
Holding current value
$286,798
Previous $417,000 30.46%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.21 - $5.81 $1,338 - $1,847
318 Added 0.46%
69,108 $290,000
Q1 2024

May 15, 2024

BUY
$5.78 - $7.33 $186,150 - $236,069
32,206 Added 88.03%
68,790 $417,000
Q4 2023

Feb 14, 2024

BUY
$3.6 - $7.15 $131,702 - $261,575
36,584 New
36,584 $256,000
Q3 2020

Nov 16, 2020

SELL
$11.59 - $14.93 $121,161 - $156,078
-10,454 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$9.31 - $21.24 $18,620 - $42,480
-2,000 Reduced 16.06%
10,454 $141,000
Q4 2019

Feb 14, 2020

BUY
$13.91 - $21.48 $173,235 - $267,511
12,454 New
12,454 $249,000
Q3 2019

Nov 14, 2019

SELL
$15.84 - $30.01 $379,320 - $718,649
-23,947 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$17.38 - $26.88 $162,346 - $251,086
9,341 Added 63.95%
23,947 $644,000
Q1 2019

May 15, 2019

BUY
$9.2 - $21.21 $134,375 - $309,793
14,606 New
14,606 $252,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $187M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.